Nairooz, Ramez

Medical School: Ain Shams University, Cairo, Egypt

Residency: New York Medical College – Metropolitan Hospital Center

Career Interest: Complex coronary and catheter based valvular interventions

Research Interest: Outcome based clinical research focusing on acute coronary syndrome and catheter based interventions

Hobbies: Soccer, finance


Selected Publications:

  1. Saad M, Gamal A, Nairooz R. TCT-210 Bivalirudin versus Heparin in Women undergoing Percutaneous Coronary Intervention: A Meta-analysis of Randomized Clinical Trials. J Am Coll Cardiol. 2016 Nov 1;68(18S):B85.
  2. Sardar P, Kundu A, Chatterjee S, Feldman D, Owan T, Nairooz R, Feldman T, Abbott JD, Elmariah S. TCT-756 Transcatheter versus Surgical Aortic-Valve Replacement in Intermediate-Risk Patients: Evidence from a Meta-analysis. J Am Coll Cardiol. 2016 Nov 1;68(18S):B305.
  3. Maskoun W, Pino MI, Ayoub K, Llanos OL, Almomani A, Nairooz R, Hakeem A, Miller J. Incidence of atrial fibrillation after atrial flutter ablation. JACC: Clinical Electrophysiology 2016 Nov 1;2(6):682-690.
  4. Nairooz R, Valgimigli M, Rochlani Y, Pothineni NV, Raina S, Sardar P, Mukherjee D, Naidu SS, Shavelle DM. Meta-analysis of clopidogrel pretreatment in acute coronary syndrome patients undergoing invasive strategy. Int J Cardiol. 2017 Feb 15;229:82-89.
  5. Saad M, Mahmoud AN, Elgendy IY, Abuzaid A, Barakat AF, Elgendy AY, Al-Ani M, Mentias A, Nairooz R, Bavry AA, Mukherjee D. Cardiovascular outcomes with sodium-glucose cotransporter-2 inhibitors in patients with type II diabetes mellitus: A meta-analysis of placebo-controlled randomized trials. Int J Cardiol. 2017 Feb 1;228:352-358.
  6. Raina S, Lensing SY, Nairooz R, Pothineni NV, Hakeem A, Bhatti S, Pandey T. Prognostic Value of Late Gadolinium Enhancement CMR in Systemic Amyloidosis. JACC Cardiovasc Imaging. 2016 Nov;9(11):1267-1277.
  7. Saad M, Nairooz R, Aronow WS. Letter by Saad et al Regarding Article, “Outcomes With Intravascular Ultrasound-Guided Stent Implantation: A Meta-Analysis of Randomized Trials in the Era of Drug-Eluting Stents”. Circ Cardiovasc Interv. 2016 Aug;9(8).
  8. Sardar P, Chatterjee S, Kundu A, Samady H, Owan T, Giri J, Nairooz R, Selzman CH, Heusch G, Gersh BJ, Abbott JD, Mukherjee D, Fang JC. Remote ischemic preconditioning in patients undergoing cardiovascular surgery: Evidence from a meta-analysis of randomized controlled trials. Int J Cardiol. 2016 Oct 15;221:34-41.
  9. Ayoub K, Nairooz R, Almomani A, Marji M, Paydak H, Maskoun W. Perioperative Heparin Bridging in Atrial Fibrillation Patients Requiring Temporary Interruption of Anticoagulation: Evidence from Meta-analysis. J Stroke Cerebrovasc Dis. 2016 Sep;25(9):2215-21.
  10. Pothineni NV, Shah NS, Rochlani Y, Nairooz R, Raina S, Leesar MA, Uretsky BF, Hakeem A. U.S. Trends in Inpatient Utilization of Fractional Flow Reserve and Percutaneous Coronary Intervention. J Am Coll Cardiol. 2016 Feb 16;67(6):732-3.
  11. Nairooz R, Ayoub K, Sardar P, Payne J, Almomani A, Pothineni NV, Shailesh F, Aronow WS, Mukherjee D. Uninterrupted New Oral Anticoagulants Compared With Uninterrupted Vitamin K Antagonists in Ablation of Atrial Fibrillation: A Meta-analysis. Can J Cardiol. 2016 Jun;32(6):814-23.
  12. Ayoub K, Nairooz R. Duration of Triple Therapy: A Clinical Question Remains Unanswered. Clin Cardiol. 2015 Dec;38(12):777.
  13. Nairooz R, Ayoub K, Shavelle D. Duration of Triple Therapy: A Clinical Question Yet to Be Answered. J Am Coll Cardiol. 2015 Nov 17;66(20):2266.
  14. Nairooz R, Feldman DN, Rochlani Y, Aronow WS, Sardar P, Mukherjee D, Naidu SS, Patel P. Impact of intraprocedural thrombotic events on short- and long-term outcomes following percutaneous coronary intervention. Evidence from a meta-analysis. Int J Cardiol. 2016 Jan 1;202:469-76.
  15. Sardar P, Kundu A, Chatterjee S, Nohria A, Nairooz R, Bangalore S, Mukherjee D, Aronow WS, Lavie CJ. Long-term cardiovascular mortality after radiotherapy for breast cancer: A systematic review and meta-analysis. Clinical cardiology 2016 Nov 2.
  16. Ayoub K, Marji M, Nairooz R. Antithrombotic and Antiplatelet Therapy in Patients Requiring Oral Anticoagulation After Percutaneous Coronary Intervention. Am J Cardiol. 2015 Sep 1;116(5):828-9.
  17. Sen P, Kundu A, Sardar P, Chatterjee S, Nairooz R, Amin H, Aronow WS. Outcomes After Cardioversion in Atrial Fibrillation Patients Treated with Non-Vitamin K Antagonist Oral Anticoagulants (NOACs): Insights from a Meta-Analysis. Am J Cardiovasc Drugs. 2016 Feb;16(1):33-41.
  18. Sardar P, Chatterjee S, Giri J, Kundu A, Tandar A, Sen P, Nairooz R, Huston J, Ryan JJ, Bashir R, Parikh SA, White CJ, Meyers PM, Mukherjee D, Majersik JJ, Gray WA. Endovascular therapy for acute ischaemic stroke: a systematic review and meta-analysis of randomized trials. Eur Heart J. 2015 Sep 14;36(35):2373-80.
  19. Nairooz R, Vallurupalli S, Agrawal M. Letter by Nairooz et al Regarding Article, “Improved Quality of Life After 1 Year With an Invasive Versus a Noninvasive Treatment Strategy in Claudicants: One-Year Results of the Invasive Revascularization or Not in Intermittent Claudication (IRONIC) Trial”. Circulation. 2015 May 26;131(21):e507.
  20. Nairooz R, Sardar P, Amin H, Chatterjee S, Helmy T, Naidu SS. Short- and long-term outcomes in diabetes patients undergoing percutaneous coronary intervention with bivalirudin compared with heparin and glycoprotein IIb/IIIA inhibitors: A meta-analysis of randomized trials. Catheter Cardiovasc Interv. 2015 Sep;86(3):364-75.
  21. Nairooz R, Sardar P, Aronow WS. Not All NSTEMIs Are Created Equal. J Am Coll Cardiol. 2015 Apr 28;65(16):1718.
  22. Nairooz R, Sardar P, Payne J, Aronow WS, Paydak H. Meta-analysis of major bleeding with uninterrupted warfarin compared to interrupted warfarin and heparin bridging in ablation of atrial fibrillation. Int J Cardiol. 2015;187:426-9.
  23. Nairooz R, Sardar P, Pino M, Aronow WS, Sewani A, Mukherjee D, Paydak H, Maskoun W. Meta-analysis of risk of stroke and thrombo-embolism with rivaroxaban versus vitamin K antagonists in ablation and cardioversion of atrial fibrillation. Int J Cardiol. 2015;187:345-53.
  24. Sardar P, Kundu A, Nairooz R, Chatterjee S, Ledley GS, Aronow WS. Health resource variability in the achievement of optimal performance and clinical outcome in ischemic heart disease. Curr Cardiol Rep. 2015 Feb;17(2):1.
  25. Sardar P, Nairooz R, Pekler G. Letter by Sardar et al regarding article, “optimal duration of dual antiplatelet therapy after drug-eluting stent implantation: a randomized, controlled trial”. Circulation. 2014 Oct 28;130(18):e160.
  26. Sardar P, Chatterjee S, Herzog E, Nairooz R, Mukherjee D, Halperin JL. Novel oral anticoagulants in patients with renal insufficiency: a meta-analysis of randomized trials. Can J Cardiol. 2014 Aug;30(8):888-97.
  27. Nairooz R, Sardar P, Amin H, Swaminathan RV, Kim LK, Chatterjee S, Feldman DN. Meta-analysis of randomized clinical trials comparing bivalirudin versus heparin plus glycoprotein IIb/IIIa inhibitors in patients undergoing percutaneous coronary intervention and in patients with ST-segment elevation myocardial infarction. Am J Cardiol. 2014 Jul 15;114(2):250-9.
  28. Sardar P, Nairooz R, Chatterjee S. Intensive glucose control for acute myocardial infarction: an unresolved clinical conundrum. JAMA Intern Med. 2014 May;174(5):825-6.
  29. Sardar P, Nairooz R, Chatterjee S, Wetterslev J, Ghosh J, Aronow WS. Meta-analysis of risk of stroke or transient ischemic attack with dabigatran for atrial fibrillation ablation. Am J Cardiol. 2014 Apr 1;113(7):1173-7.
  30. Sardar P, Nairooz R, Dutu L, Pastori LJ. Liberal versus restrictive transfusion strategy for patients with coronary artery disease. Am Heart J. 2013 Oct;166(4):e25.
  31. Sardar P, Nairooz R, Chatterjee S, Mushiyev S, Pekler G, Visco F. Cangrelor for patients undergoing percutaneous coronary intervention: evidence from a meta-analysis of randomized trials. J Thromb Thrombolysis. 2014 Jul;38(1):1-10.